Laboratory Monitoring for Methotrexate Overdose (90 mg over 4 days)
Immediately obtain a complete blood count with differential and platelet count, comprehensive metabolic panel including liver transaminases (AST/ALT), renal function tests (BUN, creatinine), and serum methotrexate level. This patient has received approximately 22.5 mg per day, which represents a potentially life-threatening overdose given that methotrexate is dosed weekly, not daily, for inflammatory conditions 1.
Critical Initial Laboratory Panel
The following tests must be ordered stat:
- Complete blood count (CBC) with differential and platelet count - to assess for bone marrow suppression, which is the leading cause of methotrexate-related fatalities 2, 1
- Serum methotrexate level - essential for determining need for leucovorin rescue therapy 1, 3
- Comprehensive metabolic panel including:
Monitoring Frequency and Follow-up
Repeat CBC and renal function tests daily until methotrexate levels fall below 0.05-0.1 μmol/L and clinical stability is achieved 1, 6. The major toxicities—myelosuppression, hepatotoxicity, and renal dysfunction—typically manifest within 5-7 days but can occur at any time 2, 7, 1.
Specific Thresholds Requiring Action:
- Hematologic: Withhold/decrease methotrexate if total WBC <3.0 × 10⁹/L, absolute neutrophil count <1.0 × 10⁹/L, or platelets <100,000/L 8, 9
- Hepatic: If transaminases exceed 2-3× upper limit of normal, consider dose reduction; if >5× normal, discontinue 2, 9
- Renal: Monitor closely as impaired renal function dramatically prolongs methotrexate elimination and increases toxicity risk 1, 3
Additional Considerations
Obtain a chest X-ray if any respiratory symptoms develop (cough, dyspnea), as pulmonary toxicity, though rare, can be life-threatening 2, 10, 1. Methotrexate-induced pneumonitis presents with dyspnea, dry cough, and fever.
Critical Management Points:
The patient likely requires leucovorin (folinic acid) rescue therapy given the overdose magnitude 1, 3. Leucovorin dosing should be guided by serum methotrexate levels, with higher doses needed if levels remain elevated beyond expected elimination times 1.
Common pitfall: Do not obtain liver function tests within 2-4 days after methotrexate dosing as transient elevations are expected and may lead to unnecessary interventions 4, 7. However, in this overdose scenario, immediate testing is warranted regardless of timing.
Risk factors that worsen toxicity in this patient include: renal impairment, hypoalbuminemia, dehydration, concurrent use of NSAIDs, trimethoprim-sulfamethoxazole, or other drugs that interfere with methotrexate elimination 2, 1. Document all concurrent medications immediately.
The most life-threatening complication is pancytopenia leading to sepsis, which has caused the majority of methotrexate-related deaths 2. Myelosuppression typically peaks 7-10 days after exposure 2, 1. This patient requires close inpatient monitoring with daily laboratory assessment until methotrexate levels are undetectable and blood counts stabilize.